Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Rare Cancers Working Group (RCWG), a 36 strong multi-stakeholder partnership, founded in 2008 and coordinated by the European Society for Medical Oncology (ESMO), brings together scientific societies, patient and research organizations, healthcare and education providers, and the industry.
The Rare Cancers Working Group (RCWG) has been established as a partnership of cooperating stakeholders with the scope to place the issue of rare cancers firmly on the European policy agenda, to identify and promote appropriate solutions, and exchange best practice.
The RCWG initiative currently includes 36 partners grouped into 5 main stakeholder groups (scientific societies, patient and research organisations, healthcare and education providers, and the industry).
An inspiring programme for future ESMO leaders
The Rare Cancers Working Group (RCWG) is an initiative that brings together stakeholders, and it composed of 36 independent national and European stakeholders representing scientific societies, patient and research organisations, healthcare and education providers, and the industry.
The Rare Cancers Working Group is grateful to the following companies and organisations for their support of the initiative.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
